obese
We conclude that (1) serum TNFalpha is increased in       normal-weight women with PCOS and is even higher in obese individuals regardless        of whether they have PCOS; (2) factors other than obesity are the cause of       elevated serum TNFalpha in normal-weight women with PCOS; and (3) whereas       increased circulating TNFalpha may mediate insulin resistance in obesity, which       may in turn promote hyperandrogenism in obese women with PCOS, it remains to be       demonstrated whether this is also the case in normal-weight women with PCOS.
We conclude that (1) serum TNFalpha is increased in       normal-weight women with PCOS and is even higher in  @SUBJECT$  @PREDICAT$  @OBJECT$  regardless        of whether they have PCOS; (2) factors other than obesity are the cause of       elevated serum TNFalpha in normal-weight women with PCOS; and (3) whereas       increased circulating TNFalpha may mediate insulin resistance in obesity, which       may in turn promote hyperandrogenism in obese women with PCOS, it remains to be       demonstrated whether this is also the case in normal-weight women with PCOS.